Dustin D Flannery
Overview
Explore the profile of Dustin D Flannery including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
57
Citations
632
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Prochaska E, Xiao S, Colantuoni E, Elhaissouni N, Clark R, Johnson J, et al.
Infect Control Hosp Epidemiol
. 2025 Feb;
:1-7.
PMID: 39957280
Objective: To quantify the impact of patient- and unit-level risk adjustment on infant hospital-onset bacteremia (HOB) standardized infection ratio (SIR) ranking. Design: A retrospective, multicenter cohort study. Setting And Participants:...
2.
Flannery D, Ramachandran V, Schrag S
Clin Perinatol
. 2025 Feb;
52(1):15-31.
PMID: 39892950
Early-onset sepsis (EOS) remains a substantial contributor to neonatal morbidity and mortality. Continued epidemiologic surveillance of incidence, risk factors, and microbiology is paramount to developing new prevention strategies and optimizing...
3.
Mukhopadhyay S, Kaufman D, Saha S, Puopolo K, Flannery D, Weimer K, et al.
Pediatrics
. 2025 Jan;
155(2).
PMID: 39842471
Objectives: To compare incidence of late-onset sepsis (LOS) among extremely preterm infants before and during the COVID-19 pandemic. Methods: Multicenter cohort study of infants with birthweight 401 to 1000 g...
4.
5.
Proano A, Shah N, Gutierrez Guarnizo S, Miranda-Schaeubinger M, Levy M, Gilman R, et al.
JAMA Netw Open
. 2024 Dec;
7(12):e2449120.
PMID: 39621350
No abstract available.
6.
Green M, Zevallos Barboza A, Mukhopadhyay S, Gerber J, Morowitz M, Puopolo K, et al.
J Pediatric Infect Dis Soc
. 2024 Oct;
14(1).
PMID: 39392923
Anaerobe-targeted antibiotic (ATA) therapy may adversely impact the developing neonatal microbiome. We describe utilization patterns, potential indications, and related outcomes of ATA therapy in neonatal intensive care units across the...
7.
Flannery D, Zevallos Barboza A, Mukhopadhyay S, Gerber J, McDonough M, Shu D, et al.
Arch Dis Child Fetal Neonatal Ed
. 2024 Jul;
110(2):151-156.
PMID: 39033026
Objective: To assess trends in antibiotic use across a large cohort of extremely low birth-weight (<1000 g; ELBW) infants admitted to academic and community neonatal intensive care units (NICUs) across...
8.
Prochaska E, Xiao S, Colantuoni E, Clark R, Johnson J, Mukhopadhyay S, et al.
JAMA Pediatr
. 2024 Jun;
178(8):792-799.
PMID: 38913368
Importance: The Centers for Disease Control and Prevention plans to introduce hospital-onset bacteremia (HOB) as a health care-associated infection measure. The epidemiology and clinical characteristics of HOB among infants admitted...
9.
Zevallos Barboza A, Flannery D, Shu D, Galloway M, Dhudasia M, Bonafide C, et al.
J Pediatr
. 2024 Jun;
273:114153.
PMID: 38901777
Objective: To determine the prevalence of C-reactive protein (CRP) use in early-onset sepsis (EOS) evaluations in neonatal intensive care units (NICUs) across the US over time and to determine the...
10.
Flannery D, Shah N, Puopolo K
Semin Perinatol
. 2024 Jun;
48(4):151921.
PMID: 38871489
The maternal/newborn dyad presents special challenges to infection management. Early in the COVID-19 pandemic, lack of information regarding SARS-CoV-2 transmission and virulence made it difficult to develop appropriate care guidance...